|
1
|
Kasper DL, Fauci AS, Hauser SL, Longo DL,
Jameson JL and Loscalzo J: Harrison's principles of internal
medicine 19/E. 1 & 2:2015.
|
|
2
|
Park CG, Bottino R and Hawthorne WJ:
Current status of islet xenotransplantation. Int J Surg.
23:261–266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tomimaru Y, Ito T, Kawamoto K, Hama N,
Wada H, Kobayashi S, Eguchi H, Tanemura M, Mori M, Doki Y and
Nagano H: Clinical outcome of pancreas transplantation from
marginal donors in Japan. Transplant Proc. 46:954–957. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Machida T, Tanemura M, Ohmura Y, Tanida T,
Wada H, Kobayashi S, Marubashi S, Eguchi H, Ito T, Nagano H, et al:
Significant improvement in islet yield and survival with modified
ET-Kyoto solution: ET-Kyoto/Neutrophil elastase inhibitor. Cell
Transplant. 22:159–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohmura Y, Tanemura M, Kawaguchi N, Machida
T, Tanida T, Deguchi T, Wada H, Kobayashi S, Marubashi S, Eguchi H,
et al: Combined transplantation of pancreatic islets and adipose
tissue-derived stem cells enhances the survival and insulin
function of islet grafts in diabetic mice. Transplantation.
90:1366–1373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mizushima T, Takahashi H, Takeyama H,
Naito A, Haraguchi N, Uemura M, Nishimura J, Hata T, Takemasa I,
Yamamoto H, et al: A clinical trial of autologous adipose-derived
regenerative cell transplantation for a postoperative
enterocutaneous fistula. Surg Today. 46:835–842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Konno M, Hamabe A, Hasegawa S, Ogawa H,
Fukusumi T, Nishikawa S, Ohta K, Kano Y, Ozaki M, Noguchi Y, et al:
Adipose-derived mesenchymal stem cells and regenerative medicine.
Dev Growth Differ. 55:309–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kawamoto K, Konno M, Nagano H, Nishikawa
S, Tomimaru Y, Akita H, Hama N, Wada H, Kobayashi S, Eguchi H, et
al: CD90-(Thy-1-) high selection enhances reprogramming capacity of
murine adipose-derived mesenchymal stem cells. Dis Markers.
35:573–579. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akinci E, Banga A, Tungatt K, Segal J,
Eberhard D, Dutton JR and Slack JM: Reprogramming of various cell
types to a beta-like state by Pdx1, Ngn3 and MafA. PLoS One.
8:e824242013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okita K, Mizuguchi T, Shigenori O, Ishii
M, Nishidate T, Ueki T, Meguro M, Kimura Y, Tanimizu N, Ichinohe N,
et al: Pancreatic regeneration: Basic research and gene regulation.
Surg Today. 46:633–640. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lumelsky N: Small molecules convert
fibroblasts into islet-like cells avoiding pluripotent state. Cell
Metab. 19:551–552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu J, Dong H, Lin L, Wang Q, Huang L and
Tan J: miRNA-302 facilitates reprogramming of human adult
hepatocytes into pancreatic islets-like cells in combination with a
chemical defined media. Biochem Biophys Res Commun. 453:405–410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyoshi N, Ishii H, Nagano H, Haraguchi N,
Dewi DL, Kano Y, Nishikawa S, Tanemura M, Mimori K, Tanaka F, et
al: Reprogramming of mouse and human cells to pluripotency using
mature microRNAs. Cell Stem Cell. 8:633–638. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyazaki J, Araki K, Yamato E, Ikegami H,
Asano T, Shibasaki Y, Oka Y and Yamamura K: Establishment of a
pancreatic beta cell line that retains glucose-inducible insulin
secretion: Special reference to expression of glucose transporter
isoforms. Endocrinology. 127:126–132. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pedica F, Beccari S, Pedron S, Montagna L,
Piccoli P, Doglioni C and Chilosi M: PDX-1 (pancreatic/duodenal
homeobox-1 protein 1). Pathologica. 106:315–321. 2014.PubMed/NCBI
|
|
18
|
Zito E, Chin KT, Blais J, Harding HP and
Ron D: ERO1-beta, a pancreas-specific disulfide oxidase, promotes
insulin biogenesis and glucose homeostasis. J Cell Biol.
188:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
May D, Itin A, Gal O, Kalinski H,
Feinstein E and Keshet E: Ero1-L alpha plays a key role in a
HIF-1-mediated pathway to improve disulfide bond formation and VEGF
secretion under hypoxia: Implication for cancer. Oncogene.
24:1011–1020. 2005. View Article : Google Scholar : PubMed/NCBI
|
